Patent · US Expired

Alteration of cellular behavior by antisense modulation of mRNA processing

US6210892A · kind A · utility

245Cited by

2References

31Claims

0Family size

Assignee

Isis Pharmaceuticals, Inc. · US

Inventors

C. Frank Bennett · Carlsbad, US
Stanley Cooke · Carlsbad, US
Muthiah Manoharan · Carlsbad, US
Jacqueline Wyatt · Carlsbad, US
Brenda F. Baker · Carlsbad, US
Brett P. Monia · Carlsbad, US
Susan M. Freier · San Diego, US
Robert McKay · Poway, US
James Karras · San Marcos, US

Key dates

Filing date	Mar 26, 1999
Grant date	Apr 3, 2001
Priority date	—
Expiry date	Mar 26, 2019

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for controlling the behavior of a cell, tissue or organism through antisense modulation of mRNA processing, using antisense compounds which does not support cleavage of the mRNA target.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.